Answers are grounded in this paper and cite their sources.
Reveals the role of microrna-6833-3p in prostate cancer progression, suggesting new therapeutic targets.
Understanding molecular pathways in prostate cancer (PCa) is essential. This study demonstrates that miR-6833-3p plays a key role in prostate tumorigenesis via multi-omics integration and functional validation. Expression levels of miR-6833-3p, NUMB, and NOTCH1 were measured in PCa cell lines. The direct regulation of NUMB by miR-6833-3p was confirmed via dual-luciferase reporter assays with mutagenesis. Functional effects were examined using NUMB plasmids or miR-6833-3p mimics. Cell function assays and xenograft models in nude mice were employed, with tissues analyzed via HE staining, qRT-PCR, and Western blot. miR-6833-3p and NOTCH1 were upregulated in PCa, while NUMB was downregulated. miR-6833-3p mimics promoted proliferation, migration, and stemness but inhibited apoptosis and the NUMB/NOTCH1 pathway. NUMB overexpression reversed these effects. In vivo, miR-6833-3p accelerated tumor growth and suppressed NUMB/NOTCH1. miR-6833-3p promotes PCa progression and stemness by inhibiting the NUMB-NOTCH pathway, highlighting its potential as a biomarker for detection and targeted therapy.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: